| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |